Trial Profile
Safety of eslicarbazepine acetate in combination with other non-inducer antiepileptic drugs in patients with epilepsy: A multicentre, retrospective, observationa study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2018
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- 22 Jul 2018 New trial record